In this Healio Video Perspective from Retina 2025, Ramiro Ribeiro, MD, PhD, of EyePoint Pharmaceuticals, discusses Duravyu, a vorolanib intravitreal insert. According to Ribeiro, in the DAVIO 2 trial, ...
Blood tests for cyclic adenosine monophosphate may be a simple and useful option for diagnosing asthma and determining its ...
Medicare beneficiaries with emphysema who received an endobronchial valve vs. lung volume reduction surgery faced elevated ...
In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...
Use of PubMed’s conflict-of-interest field has increased over time, but utilization remains limited, according to research ...
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...
The addition of high-dose IV vitamin C to standard chemotherapy nearly doubled OS for patients with advanced pancreatic cancer, according to results of a randomized phase 2 trial.Vitamin C also ...
Nearly 70% of adolescents report having at least one social media account, including 63.8% of youth aged younger than 13 ...
The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and ...
BP readings taken in public spaces vs. those taken in private offices appeared similar, results from a randomized crossover ...
A study of pediatric skiing-related injuries showed rates of sprains and contusions decreased, while rates of fractures and ...
The Janus kinase inhibitor baricitinib, in combination with narrowband ultraviolet B therapy, improved vitiligo, according to a study.“The use of phototherapy alongside [Janus kinase (JAK)] inhibitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback